PPM1D

Targeting PPM1D Overexpression in Myeloproliferative Neoplasms: Molecular Insights and Therapeutic Advances

PPM1D mutations and overexpression are involved in MPN pathogenesis, with dual PPM1D and HDM2 inhibition emerging as a promising therapeutic strategy, particularly for myelofibrosis patients.